skip to Global Navigation Bar skip to main content


homeHome > Press Release > News

News

News Content
Daewoong Pharmaceuticals presents result of phase 3 clinical trial on Supect at The Korean Society of Hematology
Date 2016-05-31 Hit 2434
list
News List
Prev Daewoong Pharmaceuticals receives Prime Minister Commendation as an ‘Outstanding Company in Fair Gender Employment’
Next Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension